Gyre Therapeutics Inc. (GYRE) — Strategic Asset Allocation Index
Gyre Therapeutics Inc. (GYRE) has a Strategic Asset Allocation Index of 21.5% as of March 2026. Strategic assets (PP&E of $- plus long-term investments of $29.42 Million) total $29.42 Million, measured against net assets of $136.99 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check Gyre Therapeutics Inc. asset resilience ratio to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Gyre Therapeutics Inc. Strategic Asset Allocation Index (2021–2025)
This chart shows how Gyre Therapeutics Inc.'s Strategic Asset Allocation Index has evolved across 5 annual periods from 2021 to 2025. As of March 2026, the index stands at 21.5%, representing strategic assets of $29.42 Million against net assets of $136.99 Million USD. See GYRE free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Gyre Therapeutics Inc. (2021–2025)
The table below presents the year-by-year Strategic Asset Allocation Index for Gyre Therapeutics Inc. from 2021 to 2025, covering 5 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see how much is Gyre Therapeutics Inc. worth.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 16.5% | $23.52 Million | $- | $23.52 Million | $142.28 Million | ▼ -8.4 pp |
| 2024 | 25.0% | $24.57 Million | $- | $24.57 Million | $98.40 Million | ▼ -143.0 pp |
| 2023 | 168.0% | $23.43 Million | $- | $23.43 Million | $13.95 Million | ▲ +157.7 pp |
| 2022 | 10.2% | $7.39 Million | $- | $7.39 Million | $72.22 Million | ▲ +10.2 pp |
| 2021 | 0.0% | $0.00 | $- | $0.00 | $41.09 Million | — |